NUREG-1566, STC-19-019, NUREG-1566 Volume 13 Revision 2 Consolidated Guidance About Materials Licenses: Program -Specific Guidance About Commercial Radiopharmacy Licenses (Final Report)

From kanterella
Revision as of 22:03, 1 December 2019 by StriderTol (talk | contribs) (Created page by program invented by StriderTol)
Jump to navigation Jump to search
STC-19-019, NUREG-1566 Volume 13 Revision 2 Consolidated Guidance About Materials Licenses: Program -Specific Guidance About Commercial Radiopharmacy Licenses (Final Report)
ML19080A196
Person / Time
Issue date: 03/28/2019
From: Andrea Kock
Office of Nuclear Material Safety and Safeguards
To:
McMurtary Anthony MSST/MSLB, 415-2746
References
STC-19-019
Download: ML19080A196 (3)


Text

STC UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 March 28, 2019 ALL AGREEMENT STATES, VERMONT PUBLICATION OF NUREG-1556, VOLUME 13, REVISION 2, CONSOLIDATED GUIDANCE ABOUT MATERIALS LICENSES: PROGRAM-SPECIFIC GUIDANCE ABOUT COMMERCIAL RADIOPHARMACY LICENSES (STC-19-019)

Purpose:

To inform the Agreement States, as well as any States with pending Agreement State applications, that the Office of Nuclear Material Safety and Safeguards published NUREG-1556, Volume 13, Revision 2, Consolidated Guidance About Materials Licenses:

Program-Specific Guidance About Commercial Radiopharmacy Licenses - Final Report in March 2019.

Background:

The U.S. Nuclear Regulatory Commission (NRC) is revising the licensing guidance in the NUREG-1556 series. The NRC originally published NUREG-1556, Volume 13 in September 1999 and published Revision 1 to Volume 13 in November 2007. The document is intended for use by applicants, licensees, and NRC staff, and is also available to the Agreement States.

Discussion: NUREG-1556, Volume 13, Revision 2, was updated by a working group made up of NRC and Agreement State representatives, to include safety culture, security of radioactive materials, protection of sensitive information, and changes in regulatory policies and practices.

The volume was also reviewed by a steering committee made up of NRC management and an Agreement State manager. After the steering committee review, the NRC regional offices and NRC legal staff reviewed the document and then NMSS, Division of Materials Safety, Security, State, and Tribal Programs management approved the volume for publication Revision 2 of Volume 13 can be found on the NRCs public Web site at:

http://www.nrc.gov/reading-rm/doc-collections/nuregs/staff/sr1556/

STC-19-019 If you have any questions on this correspondence, please contact the individual named below:

POINT OF CONTACT: Mr. Anthony McMurtray E-MAIL: Anthony.McMurtray@nrc.gov TELEPHONE: (301) 415-2746

/RA by Paul Michalak for/

Andrea L. Kock, Director Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguard

STC-19-019

SUBJECT:

PUBLICATION OF NUREG-1556, VOLUME 13, REVISION 2, CONSOLIDATED GUIDANCE ABOUT MATERIALS LICENSES: PROGRAM-SPECIFIC GUIDANCE ABOUT COMMERCIAL RADIOPHARMACY LICENSES (STC-19-019)

DATED: MARCH 28, 2019 DISTRIBUTION:

CRCPD OAS ML19080A196 OFFICE NMSS/MSST NMSS/MSST NMSS/ASPB NMSS/MSST NAME AMcMurtray AMcMurtray for: PMichalak PMichalak for:

HGonzalez AKock DATE 03/22/19 03/22/19 03/28/19 03/28/19 OFFICIAL RECORD COPY